When Jim O’Neill was nominated to be the second in command at the US Department of Health and Human Services, longevity enthusiasts were excited.
As Robert F. Kennedy Jr.’s new right-hand man, O’Neill is expected to wield authority at health agencies that fund biomedical research and oversee the regulation of new drugs. And while O’Neill doesn’t subscribe to Kennedy’s most contentious beliefs—and supports existing vaccine schedules—he may still steer the agencies in controversial new directions.
O’Neill is well-known in the increasingly well-funded and tight-knit longevity community. In speaking with more than 20 people who work in the longevity field and are familiar with O’Neill, it’s clear that they share a genuine optimism about his leadership. Read our story all about him and what he believes.
—Jessica Hamzelou
Inside OpenAI’s empire with Karen Hao
AI journalist Karen Hao’s newly released book, Empire of AI: Dreams and Nightmares in Sam Altman’s OpenAI, tells the story of OpenAI’s rise to power and its far-reaching impact all over the world.
Hao, a former MIT Technology Review senior editor, will join our executive editor Niall Firth in an intimate subscriber-exclusive Roundtable conversation exploring the AI arms race, what it means for all of us, and where it’s headed. Register here to join us at 9am ET today!
Special giveaway: Attendees will have the chance to receive a free copy of Hao’s book. See the registration form for details.
